Report
MarketLine Department
EUR 297.75 For Business Accounts Only

Pharmaceuticals in Asia-Pacific

Pharmaceuticals in Asia-Pacific

Summary

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Asia-Pacific pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Asia-Pacific pharmaceuticals market had total revenues of $291.0bn in 2017, representing a compound annual growth rate (CAGR) of 6.4% between 2013 and 2017.
- Countries such as China, India and Indonesia are experiencing strong growth due to a bourgeoning middle class which spend more on health and greater awareness of chronic diseases.
- South Korea and Japan contrast the performance of the region as a whole. Low rates of growth show those markets are mature and pressure is exerted on leading pharmaceutical companies to keep costs down amid greater demands being placed upon the healthcare system.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Asia-Pacific pharmaceuticals market by value in 2017?
- What will be the size of the Asia-Pacific pharmaceuticals market in 2022?
- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Asia-Pacific's pharmaceuticals market?
Provider
MarketLine
MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

 For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

 MarketLine’ holistic business intelligence report collection includes:

 Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

 Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

 Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

Analysts
MarketLine Department

Other Reports from MarketLine

ResearchPool Subscriptions

Get the most out of your insights

Get in touch